Advanced search
Publication Cover
Journal of Medical Economics Volume 21, 2018 - Issue 11
Submit an article Journal homepage
1,137
Views
7
CrossRef citations to date
0
Altmetric
Oncology

A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-type RAS metastatic colorectal cancer in the US

Christopher N. GrahamRTI Health Solutions, Research Triangle Park, NC, USA; Correspondence[email protected]
,
Alexandra ChristodoulopoulouAmgen Inc., Thousand Oaks, CA, USA;
,
Hediyyih N. KnoxRTI Health Solutions, Research Triangle Park, NC, USA;
,
Lorenzo SabatelliAmgen GmbH, Zug, Switzerland;
,
Guy HechmatiAmgen Inc., Thousand Oaks, CA, USA;
,
Tamer GarawinAmgen Inc., Thousand Oaks, CA, USA;
&
John H. StricklerDuke University, Durham, NC, USA
 show all
Pages 1075-1083 | Received 07 Jun 2018, Accepted 06 Aug 2018, Published online: 28 Sep 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.